Venture capital at the edge of possibility
Yesterday's science fiction.
Tomorrow's new truth.
We look for companies turning once-impossible ideas into real science. The films imagined the questions. The founders are building the technologies that could change the answers.
Explore the connections ↓
Our thesis
Three stories. Four companies.
A different view of what comes next.
Science fiction is our starting point, not our evidence. We follow the science, the people and the path from an ambitious idea to a useful technology.
01 / Gattaca / 1997
When biology becomes information
Gattaca asks who controls genetic information. Nucleus brings embryo genetic analysis into real reproductive decisions.
The imagined future
In a society that ranks people by their DNA, one man refuses to let his genetic profile decide his future. Gattaca asks who gets to choose when biology becomes readable.
The company connection
Nucleus
Nucleus offers genetic analysis of IVF embryos to help prospective parents compare genetic information before selection.
Explore Nucleus ↗The thesis. Genetic information is becoming part of reproductive decision-making. The opportunity comes with questions about accuracy, access and choice. Risk estimates are not guarantees, and screening is not gene editing.
02 / The Matrix / 1999
When the mind meets the machine
The Matrix imagines a direct connection between mind and machine. Neuralink and Science Corporation work on real neural interfaces, with different goals.
A world experienced through a computer-generated reality puts the connection between the brain and machines at the center of the story. The real-world frontier is more grounded: new ways to interact with computers and restore function.
Computer control
Neuralink
Neuralink is developing implantable brain-computer interfaces designed to translate neural activity into control of computers and mobile devices.
Explore Neuralink ↗Vision and neural interfaces
Science Corporation
Science Corporation develops neural-interface technologies, including the PRIMA retinal implant and biohybrid neural-interface research.
Explore Science Corporation ↗The thesis. The interface may move closer to the nervous system itself. These companies work on different technologies; neither is building the fictional Matrix.
03 / Jurassic Park / 1993
When extinction becomes a question
Jurassic Park imagines biotechnology reshaping the living world. Colossal explores de-extinction and conservation, not a dinosaur theme park.
The imagined future
Genetically recreated dinosaurs turn a theme park into a test of human control over nature. Jurassic Park asks what happens when the ability to build runs ahead of the responsibility to steward.
The company connection
Colossal
Colossal develops genetic-engineering and de-extinction technologies, with projects focused on animals such as the woolly mammoth, thylacine and dodo.
Explore Colossal ↗The thesis. Biotechnology could change how we think about species loss and conservation. This is a thematic connection, not a claim that dinosaurs are coming back or that extinction has been solved.
The next chapter
The future starts as a story.
Then someone builds it.
New Truth follows that transition: from imagination to experiment, and from experiment to a new reality.
Sources and perspective
Company descriptions checked October 7, 2026. No film footage or stills are stored in this package. Company photography is linked at its source because permission for use on this fund website has not been confirmed. All new artwork is original concept illustration, not a depiction of real company products. Film summaries are original editorial descriptions. Film references are thematic, not endorsements or affiliations. Companies shown reflect the founder's stated investment focus; this page does not independently verify fund holdings. No offer to sell securities or investment advice.